RxDoctor Payments Data

Sara Feltner

Family · Scottsburg, INNPI 1033228861

Payments from drug & device makers

$2,625in general payments, 2019–2025

Across 127 payments — averaging $20.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1K
  • AbbVie$282
  • Novo Nordisk$187
  • Boehringer Ingelheim$161
  • Merck$118
  • GSK$97
  • plus $519 from 16 others

What the payments were for

  • Food & beverage$2,60299%
  • Education$231%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,625 in reported general payments places this provider in the 80th percentile of 4,392 family providers in Indiana.

See all family providers in Indiana

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide60$65,685
FarxigaDapagliflozin Propanediol57$56,073
EliquisApixaban34$25,130
Trelegy ElliptaFluticasone/Umeclidin/Vilanter30$21,896
JanuviaSitagliptin Phosphate14$11,164
JardianceEmpagliflozin11$9,826
SynthroidLevothyroxine Sodium98$8,108
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr11$5,141
Memantine Hcl ErMemantine Hcl22$4,620
Rosuvastatin Calcium338$2,952
Atorvastatin Calcium273$2,309
Nebivolol Hcl24$1,761
Pantoprazole Sodium93$1,475
Bupropion XlBupropion Hcl60$1,474
Omeprazole105$1,455

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$187$65,68560 claims
AstraZenecaFarxiga$1,261$56,07357 claims
GSKTrelegy Ellipta, Anoro Ellipta$97$27,03641 claims
PfizerEliquis$79$25,13034 claims
MerckJanuvia$118$11,16414 claims
Boehringer IngelheimJardiance$161$9,82611 claims
AbbVieSynthroid$282$8,10898 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$26$869110 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,392 family providers in Indiana.

Other family in Scottsburg

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →